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Histomorphological changes after neodymium: YAG laser-coagulation 
of the human prostate with the Side Focus fiber 
Effect of power setting and time 
Abst rac t  The objective of our study was to determine 
optimal treatment parameters and appropriate methods 
of examination for neodymium:yttrium-aluminum-garnet 
(Nd:YAG) high-power laser coagulation of the human pros- 
tate in relation to power setting and time. Transurethral 
free-beam laser coagulation was performed with the Side- 
Focus side-firing laser fiber in ten patients prior to planned 
radical surgery, of whom six underwent transperitoneal l -
paroscopic lymphadenectomy and laser coagulation 4-9 
days prior to open surgery. Depth and volume of coagu- 
lated prostatic tissue were measured at power setting/time 
combinations of 40 W/90 s and 60 W/60 s, respectively, 
while holding total energy delivery constant. Microscopic 
examination i the early phase showed that epithelial cells 
had become loose from the basal-cell membrane. By 4-9 
days there was evidence of conspicuous squamous epithe- 
lial metaplasia with a high proliferation rate as a sign ofre- 
epithelialization. Using the Side Focus side-firing laser fi- 
ber, both treatment modalities howed comparable volume 
coagulation. In contrast there was a significant difference 
between those prostates removed at 4-9 days and those re- 
moved at 60-210 min after laser coagulation. We conclude 
that laser-induced changes in the human prostate are con- 
clusively discernible only after 4 days. 
Key  words  Prostate • Benign prostatic hyperplasia • 
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Introduction 
Benign prostatic hyperplasia (BPH), which is a common 
disease affecting men, leads to micturition difficulties in 
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50% of 50-year-old men with the disease. At present wo 
to four out of every ten males over 60 years of age are op- 
erated on for BPH [3]. For many years standard treatment 
has been transurethral resection of the prostate (TURP) and 
occasionally in the case of large adenomas open prostatec- 
tomy. Both treatments, although they have proved effec- 
tive, are associated with a significant morbidity rate [8, 20]. 
Therefore minimally invasive procedures for the treatment 
of BPH are currently under debate among urologists. Vis- 
ual laser ablation of the prostate (VLAP) using neody- 
mium:yttrium-aluminum-garnet (Nd:YAG) laser is the 
main procedure in use at present. Many publications have 
considered the question of laser dosimetry and the extent 
of laser-induced coagulation using various fibers of differ- 
ent treatment modalities [2, 9-14, 17, 21]. So far the im- 
pact and extension of visual laser ablation in humans have 
rarely been subject o examination. In 1993 Bolton and Co- 
stello [4] first presented histological results from human 
prostate after Nd:YAG laser ablation. In the following years 
further studies were published ealing in particular with 
the extension of the laser-induced changes and the estab- 
lishment of fiber-specific optimal treatment modalities for 
some special ight guides with respect o time and energy 
used and method of application [5, 16, 18, 19, 23, 26, 29]. 
In this study we examined the histomorphological 
changes in human prostates following laser application 
with a specific fiber as well as carefully evaluated the ex- 
tent of coagulation i relation to the power setting and time 
used. Based on an empiricial optimal energy delivery of 
3600 J for each setting [2, 9-11, 14], we assessed the ef- 
fect of the energy (40 W/90 s vs 60 W/60 s) and time used 
on morphological changes. 
Materials and methods 
From September 1994 to June 1995 a group of ten patients with a 
mean age of 60.8 (range 55-70 years) was accepted for the study af- 
ter their written personal consent was obtained and approval obtained 
from the Ethics Committee. A transperitoneal laparoscopic lymphad- 
enectomy was performed in six patients with bioptically verified 
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Fig. 1A-D Macroscopic view of human prostate after VLAP pro- 
cedure (horizontal section, native and H & E-stained) at 210 rain 
(A, B) and at 4 days (C, D) following a 40-W/90-s power setting 
adenocarcinoma of the prostate, which was identified from the en- 
larged staging, after laser treatment and with the patient under the 
same anesthetic. Following histological examination f lymphade- 
nectomy six patients underwent radical prostatectomy 4-9 days lat- 
er. Another three patients in whom carcinoma ofthe prostate was lo- 
cated were primarily treated with radical cancer surgery. Another pa- 
tient with urothelial carcinoma underwent radical cystoprostatecto- 
my. In the latter four patients laser treatment was applied immedi- 
ately prior to the planned surgery and with the patient under the same 
anesthetic. The specimen was taken at 60-210 min following laser 
treatment. 
We used a 100-W cw-Nd:YAG laser (Dornier Medilas 4100) for 
energy delivery and the high-energy-density S deFocus fiber (Dorni- 
er), 600 #m in diameter, as the light guide. Laser treatment took place 
with the patient under insufflation anesthetic n the dorsal ithotomy 
position. It was performed under direct vision using a 23-Fr. flow- 
laser cystoscope (Circon, ACMI) under continuous irrigation with a 
new fiber for the settings of 40 W at 90 s and 60 W at 60 s, respec- 
tively. It was aimed close to the verumontanum in the 2, 4, 8 and 
10 o'clock positions and with a total energy delivery of 14400 J. 
After fixation in phosphate-buffered formalin (PBS, 10%), the 
prostatovesiculectomy specimens were sectioned horizontally into 
slides 5 mm in width, macroscopically classified and recorded nu- 
merically. Subsequently he organ slices were embedded inparaffin 
and the cut surface of the sections tained with hematoxylin a d eo- 
sin and examined under a light microscope. Laser-induced changes 
in the organ were analyzed as to their quality and extension. 
Results 
Radical prostatovesiculectomy wasperformed at an inter- 
val of 1 h to 9 days following transurethral laser ablation. 
Early changes 
On gross examination acutely harvested human prostates 
showed a zone of coagulation necrosis extending from the 
urethral lumen but with no sharp and well-defined margin. 
No clear hemorrhagic ring was observed in t]aese specimens 
removed at an early stage, with only slight peeling and 
swelling visible (Fig. 1A, B). Microscopic examination 
showed that epithelial cells of the prostate glands had loos- 
Fig. 2A-H Histology of earlier (A, E) and later (B, C, E, F, G, H) 
VLAP-induced changes in human prostate: Desquamation f dam- 
aged epithelial cells into glandular lumen (A, x 160), margin of peri- 
urethral necrotic zone with extensive hemorrhage (B, x40), granu- 
lar and histiocytic inflammation i filtration (C, x260), squamous 
epithelial metaplasia of glandular epithelium (D, x70), myxoid 
swelling and partial oss of stromal cell detail (E, × 160), coagula- 
tion necrosis of epithelial s well as strornal cell elements (F, × 125), 
pseudocystic resorption of cell dentritus (G, ×70), marked prolife- 
rative activity of the regenerating glandular epithelium (I-I, x 160, 
Mib-1 immunohistochemistry) 
$9 
S10 
ened from the basal-cell membrane and showed desquama- 
tion in the glandular lumina (Fig. 2A). Solidified chroma- 
tinic nuclei and vacuolated cytoplasm were noted. Stroma 
was found to be edematous and numerous tromal cells 
lacked nuclei (Fig. 2E). With both treatment modalities the 
laser application sites could not be identified either by car- 
bonization or by tissue disruption. 
Delayed changes 
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By 4 days after laser application a demarcated spherical 
lesion was identified periurethrally with a rim of hemor- 
o 
rhage surrounding it (Fig. 1C, D). Microscopic exam- 
ination revealed coagulative necrosis of epithelial and 
stromal cells with a nearly complete loss of cell and tissue Fig. 3 
detail. Cell nuclei were rare (Fig. 2F). Peripheral to the 
necrotic area, ectatic and in part thrombosed vessels with 
homogeneous eosinophilic walls alternating with zonal 
hemorrhage were prominent (Fig. 2B). Subsequently neu- 
trophil granulocytes and macrophages were responsible for 
the gradual clearing away of detritus to the point of leav- 
ing behind absorbent cavities of small size (Fig. 2G). In 
the prostate tissue adjacent to the necrotic region, there was "8" 
evidence of a conspicuous squamous epithelial metaplasia _6 
of the glandular epithelium (Fig. 2D). The proliferative ra- 
tio of this epithelium was 50-80% as seen in the immuno- -r- 
histochemical staining for the proliferation-associated 
antigen Ki-67 (Fig. 2H). E., 
The discernible changes at 6 or 9 days following laser 
ablation were the same as those at 4 days. Particularly not- .u 
able, however, were the absorbent and regenerative pro- 
cesses which had occurred by the later date. For both ap- 
plied treatment settings no differences were noted in the 
quality of the morphological findings. 
A confluent, periurethral necrotic area of variable di- 
mensions was found in all six cases independent of the 
power setting at which prostate specimens were taken 
between 4 and 9 days after laser treatment. Necrotic areas 
showed a homogeneous character, thus not influencing ex- 
tension by the variable tissue structure. Lesions were lim- 
ited to the transition zones and they were confined to the 
organ in all specimens (Fig. 1A, B). 
The dimension of the necrotic zones showed no major 
differences between modalities (Fig. 3). In the histologi- 
cal examination the necrosis howed a diameter of between 
2.5 and 3.3 cm transversely after application of 40 W and Patient 
60 W, respectively, with a depth of between 2.5 and 3.1 cm. 
The coagualated volume for the 40-W group was between 
6.2 and 16.4 cm 3 and between 8.4 and 11 cm 3 for the 
60-W group, respectively. Both the largest and smallest co- 1 
agulated volumes were found in the 40-W group (Table 1). 2 
3 Macroscopically aser-induced changes were not distinctly 4 
demarcated in specimens taken at an early stage 5 
60-210 rain after laser treatment (Fig. 1C, D). Microscopic 6 
changes were recorded in four cases, taking into consider- 7 
ation that the obtained values were significantly lower than 8 
those in specimens taken 4-9 days following laser irradi- 9 10 
ation (Fig. 4). 
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Fig. 4 Significant difference in necrotic volume of the removed 
prostate at two time intervals after VLAP 
Table 1 Histological results of the four-quadrant laser procedure 
(2, 4, 8, 10 o'clock) with both modatities (40 W//90 s vs 60 W/ 
60 s) with a total energy delivery of 14 400 J for each setting. (t trans- 
verse, a axial, s sagittal) 
Modality Interval Necrotic Coagulated 
extension volume 
(txsxa) (cm) (txsxaxTc/6) 
(cm 3) 
40 W/90 s 4 days 
40 W/90 s 7 days 
40 W/90 s 9 days 
60 W/60 s 7 days 
60 W/60 s 7 days 
60 W/60 s 8 days 
40 W/90 s 210 min 
40 W/90 s 120 min 
60 W/60 s 180 min 
60 W/60 s 60 rain 
3.3 x3.2x3.0 16.5 
2.5 x3.0x2.5 9.8 
2.7x2.2x2.0 6.2 
3.1 x2.6x2.0 8.4 
2.5 x2.5x3.0 9.8 
2.8 x2.7x2.8 ll 
2.7 × 1.7 x 1.5 3.6 
1.5x 1.5x2.0 2.3 
2.4x2.2x2.8 7.7 
2.2x2.0x2.l 4.8 
Discussion 
Since the first report by Johnson's et al. [10] on visual la- 
ser application for the treatment of BPH, further experi- 
mental animal reports and dosimetry studies have been 
published [2, 9, 13, 14, 19, 21, 23]. So far data from clin- 
ical trials have shown very promising results [1, 6, 7, 15, 
22]. Apart from optimal laser energy delivery and laser 
treatment time there are the different physical properties 
of the diverse light guides to be taken into consideration 
[25, 27, 30]. Not many more than a dozen fibers are cur- 
rently available, and a number of reliable studies have 
looked at their impact on human tissue [13, 16, 18, 19, 23, 
26, 29]; however, we have only three 3 light guides at our 
disposal (Urolase, Prolase II and Ultraline). In this paper 
we present he results of thermal coagulation in human 
prostates following laser treatment using a SideFocus fi- 
ber with subsequent systematic histopatholgoical exam- 
ination. In addition to comparing the two procedure modes, 
we also evaluated laser-induced changes in relation to 
treatment time. 
Visual prostate laser application in four quadrants inde- 
pendent of power setting produces a confluent periureth- 
ral necrotic area of variable xtent. Upon examination there 
were no substantial differences between irradiation power 
used as to the extent of necrotic zone; on the contrary we 
found the largest and the smallest necrotic volumes fol- 
lowing 40 W irradiation. The reasons for the different ex- 
tensions are a matter for debate: the variable tissue struc- 
ture of the prostate from person to person leads to variable 
thermal conductivity and thermal storage including vari- 
able dissipation of heat hrough the vascular system. More- 
over, the changing qualities of the light guides during treat- 
ment must be taken into account [25, 27, 30]. Although no 
differences was found in necrotic volume between both la- 
ser treatment modalities, from our experience we suggest 
using the 40-W power setting for the SideFocus fiber; at 
this setting there is little danger of the fiber being dam- 
aged, and inadvertent carbonization effects can thus be 
avoided. 
Laser treatment with the SideFocus fiber produces ther- 
mocoagulation as reported by several authors [4, 13, 16, 
19, 23, 26]. The maximum extension i  the transverse plane 
(1.65 cm in radius) is nearly identical to that (l.75 cm) 
noted by Shanberg et al. [26] upon irradiation with the Pro- 
lase II fiber [26]. To lase the lateral obe, Shanberg et al. 
used a dose higher than 50 000 J, targeting the whole sur- 
face extensively. Thus he achieved satisfactory ablation. 
We, however, used only a dose of 7200 J delivered at two 
spots for each lateral lobe. There is some doubt whether 
by increasing the applied energy up to more than 7200 J 
for each lobe, the depth of penetration and necrotic vol- 
ume increased significantly. Dosimetry studies by Kabalin 
et al. [13, 16, 19] show that from a certain energy dose on- 
ward the tissue effect plateaus irrespective ofthe fiber type. 
This is probably due to the thermic and optical qualities of 
the tissue (heat storage, thermal transfer, light scatter) be- 
ing altered through thermocoagulation. Moreover, we have 
S l l  
to take into account that with high-energy doses over a long 
period the above-noted damage to the fiber top appears in- 
creasingly likely to occur [27, 30]. 
For thermoregulation effects to become vident a cer- 
tain period of time is needed, but we require further details 
as to its length. The specimens taken between 1 and 3.5 h 
showed no macroscopically laser-induced lesions. Micro- 
scopic examination revealed istinctly smaller areas of dis- 
cernible necrosis than in the group of specimens taken 
4-9 days following treatment (Table 1). This confirms ear- 
lier statements by other authors that a period longer than 
only several hours is required for laser-induced changes to 
turn into discernible demarcated lesions [28]. The earliest 
interval for this to occur in our study was 4 days. With this 
specimen (Fig. 1A, B) the periurethral necrotic zone had 
reached its final state following laser treatment. Therefore 
we suggest that laser-induced changes in human prostates 
are not conclusively discernible until 1 or 2 days after treat- 
ment at the earliest. 
Laser radiation of the prostate histologically showed a 
coagulative necrosis of epithelial and stromal cells with 
ectatic and in part thrombosed vessels peripheral to ne- 
crotic zones. A homogeneous necrotic area not influenc- 
ing extension by a variable tissue structure was present in 
all specimens. Furthermore, the lesions were limited to the 
transition zone and were confined to the organ in all spec- 
imens. Gradual clearing of detritus by neutrophil granu- 
locytes and macrophages commenced and led to resorptive 
cavities of small size. Conspicuous quamous epithelial 
metaplasia of the glandular epithelium with a high prolife- 
ration rate was sign of re-epithelialization was present as 
soon as 4 days after laser application with the resorptive 
and regenerative faculties in those specimens removed at 
6 or 9 days being particularly notable, in accordance with 
the findings of other authors [5, 24]. 
We conclude that laser treatment with the SideFocus fi- 
ber in a four-quadrant procedure is a safe way of produc- 
ing a spherical zone of periurethral coagulative necrosis. 
Although there were no differences between both power 
modalities and the fibers used, we recommend a 40-W/ 
90-s combination to give slow heating and thus avoid car- 
bonization and vaporization at the application site in the 
urethra. For further dosimetry studies in human prostates 
we suggest hat evaluation of the laser-induced coagula- 
tive necrotic zone be carried out after an interval of only 
4 days. 
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